Although the increases in TRAIL in these cells are minimal, surface TRAIL induction following ONC201 treatment in breast cancer cells where the effects of the compound involve TRAIL-dependent apoptosis (MDA-MB-468, SUM149PT) [18] is also less than 2-fold above vehicle (Figure 2C). The gene discussed is TNFSF10; the disease is breast cancer.